Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
3.530
+0.220 (6.65%)
At close: Jun 21, 2024, 4:00 PM
3.528
-0.002 (-0.06%)
After-hours: Jun 21, 2024, 4:16 PM EDT

Lisata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 1995
Market Capitalization
292220502826
Upgrade
Market Cap Growth
-11.75%-60.48%81.39%6.25%-25.50%
Upgrade
Enterprise Value
-14-28-49-45-71
Upgrade
PE Ratio
-1.29-1.07-0.37-1.83-3.40-1.35
Upgrade
PB Ratio
0.680.460.300.550.851.25
Upgrade
P/FCF Ratio
-1.37-1.11-0.93-2.26-3.14-1.38
Upgrade
P/OCF Ratio
-1.37-1.11-0.94-2.26-3.14-1.38
Upgrade
EV/EBITDA Ratio
0.761.230.871.540.36-0.05
Upgrade
EV/EBIT Ratio
0.751.220.871.540.36-0.05
Upgrade
EV/FCF Ratio
0.921.412.302.000.77-0.05
Upgrade
Quick Ratio
8.137.6710.8521.009.864.21
Upgrade
Current Ratio
8.928.1811.2621.2710.084.35
Upgrade
Return on Equity (ROE)
-39.70%-37.90%-70.10%-27.10%-26.90%-70.00%
Upgrade
Return on Assets (ROA)
-35.90%-34.50%-65.90%-26.00%-23.70%-56.80%
Upgrade
Return on Capital (ROIC)
-59.23%-53.39%-86.52%-31.49%-58.91%-96.52%
Upgrade
Earnings Yield
-68.38%-93.79%-272.69%-54.59%-29.38%-74.17%
Upgrade
FCF Yield
-64.32%-90.15%-107.90%-44.33%-31.88%-72.33%
Upgrade
Buyback Yield / Dilution
-3.84%-55.85%-40.46%-258.27%-49.54%-6.56%
Upgrade
Total Shareholder Return
-3.84%-55.85%-40.46%-258.27%-49.54%-6.56%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).